Cargando…

Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice

The adipokine plasminogen activator inhibitor (PAI)-1 is increased in plasma of obese individuals and exhibits increased expression in the stomachs of individuals infected with Helicobacter. To investigate the relevance of gastric PAI-1, we used 1.1 kb of the H(+)/K(+)β subunit promoter to overexpre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kenny, Susan, Gamble, Joanne, Lyons, Suzanne, Vlatković, Nikolina, Dimaline, Rod, Varro, Andrea, Dockray, Graham J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2013
Materias:	Energy Balance-Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724960/ https://www.ncbi.nlm.nih.gov/pubmed/23254194 http://dx.doi.org/10.1210/en.2012-1913

Ejemplares similares

A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling
por: Koncarevic, Alan, et al.
Publicado: (2012)

11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms
por: Harno, Erika, et al.
Publicado: (2013)

Loss of Agouti-Related Peptide Does Not Significantly Impact the Phenotype of Murine POMC Deficiency
por: Corander, Marcus P., et al.
Publicado: (2011)

Role of Medium- and Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase in the Regulation of Body Weight and Thermogenesis
por: Schulz, Nadja, et al.
Publicado: (2011)

Sexual Dimorphism in Offspring Glucose-Sensitive Hypothalamic Gene Expression and Physiological Responses to Maternal High-Fat Diet Feeding
por: Dearden, Laura, et al.
Publicado: (2014)

Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice
por: Dowman, Joanna K., et al.
Publicado: (2013)

Differential Acute and Chronic Effects of Leptin on Hypothalamic Astrocyte Morphology and Synaptic Protein Levels
por: García-Cáceres, Cristina, et al.
Publicado: (2011)

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice()
por: Gamble, Joanne, et al.
Publicado: (2013)

The role of plasminogen activator inhibitor-1 in gastric mucosal protection
por: Kenny, Susan, et al.
Publicado: (2013)

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008)

Qualitative inquiry with primary care providers and specialists about adult weight management care and referrals
por: Bailey-Davis, Lisa, et al.
Publicado: (2022)

Sarcopenia in aging, obesity, and cancer
por: Ligibel, Jennifer A., et al.
Publicado: (2020)

Association between diabetes, obesity, aging, and cancer: review of recent literature
por: Qiang, Judy K., et al.
Publicado: (2020)

Apocalyptic horsemen of geriatric oncology
por: Berger, Nathan A.
Publicado: (2020)

The Role of Proteasome Beta Subunits in Gastrin-Mediated Transcription of Plasminogen Activator Inhibitor-2 and Regenerating Protein1
por: O’Hara, Adrian, et al.
Publicado: (2013)

Regulation of aging and cancer by enhanced environmental activation of a hypothalamic-sympathoneural-adipocyte axis
por: Hassan, Quais N., et al.
Publicado: (2020)

p16 a biomarker of aging and tolerance for cancer therapy
por: Muss, Hyman B., et al.
Publicado: (2020)

Impact of physical activity and energy restriction on immune regulation of cancer
por: Xu, Yitong, et al.
Publicado: (2020)

Acquired Brain Injury-Induced Hyperphagia and Obesity, Successfully Treated With a GLP-1 Agonist
por: Ngu, Michael, et al.
Publicado: (2021)

Association of Long-Term Dietary Intake and Gastric Myoelectric Activity in Adults with Obesity
por: Abulmeaty, Mahmoud, et al.
Publicado: (2022)

Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity
por: Alfaradhi, Maria Z., et al.
Publicado: (2014)

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

Effects of local authority expenditure on childhood obesity
por: Liu, Dan, et al.
Publicado: (2019)

Mindfulness and the challenges of working from home in times of crisis
por: Toniolo-Barrios, Mariana, et al.
Publicado: (2021)

Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
por: Ashurst, H Louise, et al.
Publicado: (2008)

Mice Deficient for an Intestinal G Protein-Coupled Receptor Expression Have Increased Satiety During Rebound Hyperphagia
por: Yan, Shijun, et al.
Publicado: (2021)

Traditional Sunchang Gochujang Attenuates Obesity in High-Fat Diet Induced Obese Mice
por: Song, Jeong Woo, et al.
Publicado: (2022)

Obesity Paradox Does Exist
por: Hainer, Vojtech, et al.
Publicado: (2013)

A map of community-based obesity prevention initiatives in Australia following obesity funding 2009–2013
por: Whelan, Jillian, et al.
Publicado: (2015)

Obesity and Mortality in a Pooled Analysis of Three Prospective Cohorts of Korean Adults: Is Obesity Paradox the BMI Paradox?
por: Jang, Hajin, et al.
Publicado: (2022)

The prevalence of general obesity, abdominal obesity, and hypertension and its related risk factors among young adult students in Bangladesh
por: Ali, Nurshad, et al.
Publicado: (2022)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Defending the Con Side: Obesity Paradox Does Not Exist
por: Standl, Eberhard, et al.
Publicado: (2013)

Friendly Fat Theory – Explaining the Paradox of Diabetes and Obesity
por: Singla, Rajiv, et al.
Publicado: (2019)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Using NIH-ADOPT Process to Characterize Adolescents with Obesity and Prediabetes
por: Arce, Britney, et al.
Publicado: (2022)

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022)

Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
por: Fernandez, Cornelius J, et al.
Publicado: (2019)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_n81eqjtpup8u7fssm91f8ekddb